Nasopharyngeal carriage of resistant pneumococci in young South Indian infants

C L Coles1, L Rahmathullah, R Kanungo

  • 1Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

Insights

Antibiotic resistance in Streptococcus pneumoniae is a growing concern in South Indian infants. High rates of resistance to common antibiotics like cotrimoxazole and erythromycin were observed, necessitating better antibiotic stewardship.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Streptococcus pneumoniae causes severe infant infections globally.
  • Data on antibiotic resistance patterns in India are scarce.
  • Antibiotic resistance complicates the management of pneumococcal infections.

Purpose of the Study:

  • To investigate antibiotic resistance patterns of pneumococci in South Indian infants.
  • To determine the prevalence of antibiotic-resistant nasopharyngeal carriage.
  • To identify specific serotypes associated with resistance.

Main Methods:

  • Examined nasopharyngeal carriage in 464 South Indian infants (2-6 months).
  • Screened newly acquired serotypes for susceptibility to cotrimoxazole, erythromycin, and penicillin using disk diffusion.
  • Assessed prevalence of antibiotic resistance and multi-drug resistance.

Main Results:

  • Pneumococcal carriage prevalence increased from 53.9% to 70.2% between 2 and 6 months.
  • Resistance rates were 34% (penicillin), 81.1% (cotrimoxazole), and 37.2% (erythromycin).
  • Over 87% of isolates showed non-susceptibility to at least one antibiotic; less than 1% were multi-drug resistant.

Conclusions:

  • Widespread antibiotic use in South India has led to significant pneumococcal non-susceptibility.
  • Serogroups/types 6, 9, 14, 19, and 23 were frequently non-susceptible.
  • Monitoring resistance trends and prescription-only access may curb spread and improve infection management.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...